Ignite Creation Date:
2024-05-06 @ 10:50 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03362463
Status:
COMPLETED
Last Update Posted:
2021-04-01
First Post:
2017-11-06
Brief Title:
Long-Term Follow-Up and Management Patterns of Patients With Acute Coronary Syndrome in Middle East and Africa
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Long-Term Follow-Up and Management Patterns of Patients With Acute Coronary Syndrome in Middle East and Africa
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TOURACO
Brief Summary:
A multinational prospective and observational study that will assess the management of ACS in real-life practices in Middle East North Africa area
Detailed Description:
The aim of this Middle Eastern and African study is to describe the short- and long-term ie up to 3 years following the index event management in patients hospitalized for an Acute Coronary Syndrome and pharmacological management patterns in a real-life setting
The TOURACO observational study will include not only hospitals with cardiac intervention facilities but also regional and community-type hospitals that have limited if at all cardiac intervention facilities The treatments prescription will be left to the investigator discretion and will be used in accordance with the local label of each country Off-label medication is not authorized in TOURACO study
The TOURACO observational study will include not only hospitals with cardiac intervention facilities but also regional and community-type hospitals that have limited if at all cardiac intervention facilities The treatments prescription will be left to the investigator discretion and will be used in accordance with the local label of each country Off-label medication is not authorized in TOURACO study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None